Target intelligence / Profile preview

RBIS pseudogene 2 (RBISP2)

Target
RBISP2
Molecular classification
Other: Pseudogene
01

Overview

RBIS pseudogene 2 (RBISP2) is a human pseudogene, meaning it is a segment of DNA that resembles a gene but does not encode a functional protein[2][3][4]. Pseudogenes are typically the result of gene duplication or retrotransposition events followed by mutations that disrupt their coding potential[1]. While some pseudogenes may play regulatory roles, there is no evidence for any functional role for RBISP2. It is not considered a therapeutic target and has no known molecular function, disease association, or drug interactions[2][3][4]. There is some confusion because pseudogenes are occasionally included in gene databases, but they are not relevant for drug targeting or biomarker development under standard conventions. This name should not be used to refer to a therapeutic target, receptor, or enzyme, and is not suitable for structured drug discovery or pharmacology datasets.

Other names
C8orf59P2chromosome 8 open reading frame 59 pseudogene 2
02

Mechanism of action

None. There are no mechanisms of action for drugs targeting RBISP2, as it is not an active target

03

Biological functions

Other: No known protein-coding function; does not participate in canonical biological pathways in its annotated form
04

Disease associations

None. There is no established disease relevance or role for RBISP2
05

Safety considerations

None documented, as it is neither a therapeutic target nor relevant in clinical settings
06

Interacting drugs

None. No drugs are known to interact with RBISP2
07

Biomarkers

None. RBISP2 is not a biomarker for diagnosis, prognosis, or patient selection

Beyond the preview

Go deeper on RBIS pseudogene 2 (RBISP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RBIS pseudogene 2 (RBISP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call